Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
35.60
+0.66 (1.89%)
At close: Oct 15, 2025, 4:00 PM EDT
37.33
+1.73 (4.86%)
Pre-market: Oct 16, 2025, 9:06 AM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.95 billion as of October 16, 2025. Its market cap has increased by 201.49% in one year.
Market Cap
1.95B
Enterprise Value
1.60B
1-Year Change
201.49%
Ranking
Category
Stock Price
$35.60
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.95B, an increase of 142.50%. That is a compound annual growth rate of 15.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1.95B | 233.91% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |